TrialDiabetes, obesity & metabolism2025

The influence of the glucagon-like peptide-1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial.

Kelli M Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.